We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Infection Risk Minor in Outpatient Surgery

By HospiMedica International staff writers
Posted on 04 Mar 2014
A new study shows that rates of postsurgical visits for clinically significant surgical site infections (CS-SSIs) following low- to moderate-risk ambulatory surgery are low relative to all causes.

Researchers at the US Agency for Healthcare Research and Quality (AHRQ; Rockville, MD; USA), Truven Health Analytics (Bethesda, MD, USA), and other institutions conducted a retrospective analysis of ambulatory surgical procedures complicated by CS-SSIs that required a postsurgical acute care visit. More...
Index cases included 284,098 ambulatory surgical procedures (general surgery, orthopedic, neurosurgical, gynecologic, and urologic) in adult patients with low surgical risk. The main outcomes and measures were rates of 14- and 30-day postsurgical acute care visits for CS-SSIs following ambulatory surgery.

The results showed that 63.7% of all visits for CS-SSIs occurred within 14 days of the surgery, and 93.2% required inpatient treatment. The overall rate of visits for SSIs was 3.09 per 1,000 procedures during the first 14 days, while extending the period to 30 days resulted in a rate of 4.84 visits per 1,000 procedures. The rate of visits for SSIs varied by procedure: for example, at 14 days, the rate was 0.27 per 1,000 laparoscopic repairs of inguinal or femoral hernias, compared to 6.44 per 1,000 vaginal hysterectomies. The study was published in the February 19, 2014, issue of JAMA.

“The chance of a clinically significant infection after ambulatory surgery is relatively small; nonetheless, outpatient surgery related infections account for roughly one in five healthcare-associated infections,” concluded lead author Claudia Steiner, MD, and colleagues. “That seeming contradiction is explained by the fact that ambulatory surgery accounts for more than 63% of all operations in the US, so the absolute number of affected patients is large.”

Surgical site infections (including nonclinically significant ones) occur in approximately 2%–5% of patients who undergo clean extra-abdominal surgeries, such as thoracic and orthopedic surgery, and in up to 20% of patients who undergo intra-abdominal surgery interventions.

Related Links:

Agency for Healthcare Research and Quality
Truven Health Analytics



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.